Treatment outcomes and prognostic factor analyses in pulmonary or hepatic metastatic patients treated with stereotactic body radiation therapy—a single institution experience | Zendy

Wen-Tso Chuang | Zendy; Stephen Wan Leung | Zendy; Changyu Wang | Zendy; Ming-Hsiang Liou | Zendy; Chun-Kau Tse | Zendy; Ying-Chen Chang | Zendy

Open Access

Treatment outcomes and prognostic factor analyses in pulmonary or hepatic metastatic patients treated with stereotactic body radiation therapy—a single institution experience

Author(s) -

Wen-Tso Chuang,

Stephen Wan Leung,

Changyu Wang,

Ming-Hsiang Liou,

Chun-Kau Tse,

Ying-Chen Chang

Publication year - 2021

Publication title -

therapeutic radiology and oncology

Language(s) - English

Resource type - Journals

ISSN - 2616-2768

DOI - 10.21037/tro-20-56

Subject(s) - medicine , hepatocellular carcinoma , lung cancer , colorectal cancer , oncology , cancer , radiation therapy , gastroenterology

Cancer patients with distant metastasis have unfavorable prognoses, and systemic therapies have been the mainstream treatments for decades. Surgical resection and radiofrequency ablation have been considered as local curative options for limited metastatic lesions. With complete surgical resection of all metastatic lesions, the 5-year overall survival (OS) rate has been reported between 20% to 50% in patients with pulmonary metastasectomy and around 40% in patients with hepatic metastasectomy (1,2). Original Article

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research